Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1565-1573

  Rost, T ^a   Pyritz, V ^a   Rathcke, I O ^b   Gorogh T ^b   Dunne A A ^a   Werner, J A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Lysyl oxidase; Lysyl oxidase like 2; Squamous cell carcinoma; Upper aerodigestive tract

Indexed keywords

MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HEAD CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALIGNANT TRANSFORMATION; NECK CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

AMINO ACID OXIDOREDUCTASES; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MUCOUS MEMBRANE; MULTIGENE FAMILY; NEOPLASM PROTEINS; PROTEIN-LYSINE 6-OXIDASE; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0038576834     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Maki JM and Kivirikko KI: Cloning and characterization of a fourth human lysyl oxidase isoenzyme. Biochem J 15: 381-387, 2001.
2. Saux CJ, Tronecker H, Bogic L, Bryant-Greenwood GD, Boyd CD and Csiszar K: The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues. J Biol Chem 274: 12939-12944, 1990.
3. Kivirikko KI: Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 25: 113-126, 1993.
4. Siegel RC, Pinnell SR and Martin G: Cross-linking of collagen and elastin. Properties of lysyl oxidase. Biochemistry 9: 4486-4492, 1970.
5. Kagan HM and Trackman PC: Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 5: 206-210, 1991.
6. Mock BA, Contente S, Kenyon K, Friedman RM and Kozak CA: The gene for lysyl oxidase maps to mouse chromosome 18. Genomics 14: 822-823, 1992.
7. Chang YS, Svinarich DM, Yang TP and Krawetz SA: The mouse lysyl oxidase gene (Lox) resides on chromosome 18. Cytogenet Cell Genet 63: 47-49, 1993.
8. Contente S, Csiszar K, Kenyon K and Friedman RM: Structure of the mouse lysyl oxidase gene. Genomics 16: 395-400, 1993.
9. Trackman PC, Pratt AM, Wolanski A, Tang SS, Offner GD, Troxler RF and Kagan HM: Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence. Biochemistry 29: 4863-4870, 1990.
10. Trackman PC, Pratt AM, Wolanski A, Tang SS, Offner GD, Troxler RF and Kagan HM: Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence. Biochemistry 30: 8282, 1991.
11. Wu Y, Rich CB, Lincecum J, Trackman PC, Kagan HM and Foster JA: Characterization and developmental expression of chick aortic lysyl oxidase. J Biol Chem 267: 24199-24206, 1992.
12. Hämäläinen ER, Jones TA, Sheer D, Taskinen K, Pihlajaniemi T and Kivirikko KI: Molecular cloning of human lysyl oxidase and assignment of the gene to chromosome 5q23.3-31.2. Genomics 11: 508-516, 1991.
13. Hämäläinen ER, Kemppainen R, Pihlajaniemi T and Kivirikko K: Structure of the human lysyl oxidase gene. Genomics 17: 544-548, 1993.
14. Mariani TJ, Trackman PC, Kagan HM, Eddy RL, Shows TB, Boyd CD and Deak SB: The complete derived amino acid sequence of human lysyl oxidase and assignment of the gene to chromosome 5 (extensive sequence homology with the murine ras recision gene). Matrix 12: 242-248, 1992.
15. Ren C, Yang G, Timme TL, Wheeler TM and Thompson TC: Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer. Cancer Res 58: 1285-1290, 1998.
16. Layman DL, Narayanan AS and Martin GR: The production of lysyl oxidase by human fibroblasts in culture. Arch Biochem Biophys 149: 97-101, 1972.
17. Gonnerman WA, Ferrera R and Franzblau C: Measurement of medium lysyl oxidase activity in aorta smooth muscle cells. Effects of multiple medium changes and inhibition of protein synthesis. Biochemistry 20: 3864-3867, 1981.
18. Kobayashi H, Ishii M, Chanoki M, Yashiro N, Fushida H, Fukai K, Kono T, Hamada T, Wakasaki H and Ooshima A: Immunohistochemical localization of lysyl oxidase in normal human skin. Br J Dermatol 131: 325-330, 1994.
19. Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA and Sommer P: Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol 150: 497-507, 1997.
20. Li W, Nellaiappan K, Strassmaier T, Graham L, Thomas KM and Kagan HM: Localization and activity of lysyl oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci USA 94: 12817-12822, 1997.
21. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH and Kagan HM: Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2. Am J Respir Cell Mol Biol 11: 751-755, 1994.
22. Tan RS, Taniguchi T and Harada H: Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res 56: 2417-2421, 1996.
23. Liu G, Nellaiappan K and Kagan HM: Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272: 32370-32377, 1997.
24. Trackman PC, Graham RJ, Bittner HK, Carnes DL, Gilles JA and Graves DT: Inflammation-associated lysyl oxidase protein expression in vivo, and modulation by FGF-2 plus IGF-1. Histochem Cell Biol 110: 9-14, 1998.
25. Kuivaniemi H, Peltonen L and Kivirikko KI: Type IX Ehlers-Danlos syndrome and Menkes syndrome: the decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein. Am J Hum Genet 37: 798-808, 1985.
26. Wakasaki H and Ooshima A: Immunohistochemical localization of lysyl oxidase with monoclonal antibodies. Lab Invest 63: 377-384, 1990.
27. Butler E, Hardin J and Benson S: The role of lysyl oxidase and collagen crosslinking during sea urchin development. Exp Cell Res 173: 174-182, 1987.
28. Csiszar K, Entersz I, Trackman PC, Samid D and Boyd CD: Functional analysis of the promoter and first intron of the human lysyl oxidase gene. Mol Biol Rep 23: 97-108, 1996.
29. Di Donato A, Lacal JC, Di Duca M, Giampuzzi M, Ghiggeri G and Gusmano R: Micro-injection of recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras and progesterone effects on Xenopus laevis oocyte maturation. FEBS Lett 419: 63-68, 1997.
30. Mello ML, Contente S, Vidal BC, Planding W and Schenck U: Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis. Exp Cell Res 220: 374-382, 1995.
31. Giampuzzi M, Botti G, Cilli M, Gusmano R, Borel A, Sommer P and Di Donato A: Down-regulation of lysyl oxidase-induced tumorigenic transformation in nrk-49f cells characterized by constitutive activation of ras proto-oncogene. J Biol Chem 276: 29226-29232, 2001.
32. Kenyon K, Contente S, Trackman PC, Tang J, Kagan HM and Friedman RM: Lysyl oxidase and rrg messenger RNA. Science 253: 802, 1991.
33. Hajnal A, Klemenz R and Schafer R: Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts. Cancer Res 53: 4670-4675, 1993.
34. Oberhuber H, Seliger B and Schafer R: Partial restoration of pretransformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants. Mol Carcinog 12: 198-204, 1995.
35. Hämäläinen ER, Kemppainen R, Kuivaniemi H, Tromp G, Vaheri A, Pihlajaniemi T and Kivirikko K: Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. J Biol Chem 270: 21590-21593, 1995.
36. Peyrol S, Galateau-Salle F, Raccurt M, Gleyzal C and Sommer P: Selective expression of lysyl oxidase (LOX) in the stromal reactions of broncho-pulmonary carcinomas. Histol Histopathol 15: 1127-1135, 2000.
37. Trivedy C, Warnakulasuriya KA, Hazarey VK, Tavassoli M, Sommer P and Johnson NW: The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 28: 246-251, 1999.
38. Kuivaniemi H, Korhonen RM, Vaheri A and Kivirikko KI: Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. FEBS Lett 195: 261-264, 1986.
39. st Annual Meeting 41: 746, 2000.
40. Saux CJ, Saux O, Gleyzal C, Sommer P and Csiszar K: The mouse lysyl oxidase-like 2 gene (mLOXL2) maps to chromosome 14 and is highly expressed in skin, lung and thymus. Matrix Biology 19: 179-183, 2000.
41. Saux CJ, Saux O, Donlon T, Boyd CD and Csiszar K: The human lysyl oxidase-related gene (LOXL2) maps between markers D8S280 and D8S278 on chromosome 8p21.2-p21.3. Genomics 51: 305-307, 1998.
42. Saito H, Papaconstantinou J, Sato H and Goldstein S: Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence. J Biol Chem 272: 8157-8160, 1990.
43. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD and Regezi JA: Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 107: 703-710, 1981.
44. Koldovsky P, Haas I, Bier H and Ganzer U: Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases. Eur Arch Otorhinolaryngol 252: 359-365, 1995.
45. Elomaa L, Joensuu H, Kulmala J, Klemi P and Grenman R: Squamous cell carcinoma is highly sensitive to taxol, a possible new radiation sensitizer. Acta Otolaryngol 115: 340-344, 1995.
46. Contente S, Kenyon K, Rimoldi D and Friedman RM: Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249: 796-798, 1990.
47. Giampuzzi M, Botti G, Di Duca M, Arata L, Ghiggeri G, Gusmano R, Ravazzolo R and Di Donato A: Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem 275: 36341-36949, 2000.
48. Schürch W, Lagace R and Seemayer TA: Myofibroblastic stromal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet 154: 351-358, 1982.
49. Görögh T, Maune S, Lippert BM, Rudert H, Gottschlich S, Hoffmann M, Meyer J, Heidorn K and Werner JA: Transcriptional repression of the human fibronectin gene in laryngeal squamous cell carcinoma cells. J Cancer Res Clin Oncol 127: 166-172, 2000.
50. Roy R, Polgar P, Wang Y, Goldstein RH, Taylor L and Kagan HM: Regulation of lysyl oxidase and cyclooxygenase expression in human lung fibroblasts: interactions among TGF-beta, IL-1 beta, and prostaglandin E. J Cell Biochem 62: 411-417, 1996.